| In millions, except per share items | Jun-30-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Dec-31-18 | Sep-30-18 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Interest income: |
| Interest income on loans | 36.6 | 37.0 | 38.6 | 40.1 | 40.2 | 38.3 | 36.4 | 34.4 |
| Interest income on investments | 2.9 | 3.8 | 3.8 | 5.3 | 6.0 | 7.9 | 8.7 | 8.4 |
| Interest income on repurchase agreements | 0.1 | 0.6 | 0.5 | 0.8 | 0.9 | 1.0 | 0.7 | 0.6 |
| | 39.8 | 41.6 | 43.2 | 46.5 | 47.5 | 47.5 | 46.0 | 43.7 |
| Interest expense: |
| Interest on deposits | 8.9 | 12.2 | 12.6 | 15.0 | 16.7 | 17.0 | 15.9 | 14.1 |
| | 10.3 | 14.1 | 15.1 | 18.3 | 20.1 | 20.1 | 19.1 | 17.2 |
| Net interest income | 29.5 | 27.5 | 28.1 | 28.3 | 27.4 | 27.4 | 26.9 | 26.6 |
| Provision for loan losses | 3.2 | 13.0 | 19.0 | 1.0 | 7.0 | 5.1 | 1.0 | 0.1 |
| Net interest income after provision for loan losses | 26.3 | 14.4 | 9.2 | 27.3 | 20.3 | 22.4 | 25.9 | 26.4 |
| Other non-interest income | 10.6 | 5.9 | 4.6 | 4.8 | 4.9 | 3.5 | -0.4 | 3.4 |
| Total non-interest income | 10.6 | 5.9 | 4.6 | 4.8 | 4.9 | 3.5 | -0.4 | 3.4 |
| Non-interest expenses | 24.0 | 22.4 | 21.3 | 18.6 | 19.4 | 22.6 | 21.7 | 18.3 |
| Pre-tax income | 12.9 | -2.1 | -7.6 | 13.4 | 5.9 | 3.2 | 3.9 | 11.6 |
| Income taxes | 2.7 | -0.9 | -3.0 | 2.1 | 0.7 | 0.3 | 0.1 | 1.1 |
| Tax rate | 21.1% | 45.0% | 39.3% | 15.8% | 12.0% | 10.3% | 3.2% | 9.2% |
| Minority interest | 0.0 | | 0.0 | | 0.0 | | 0.0 | |
| Net income | 10.2 | -1.1 | -4.6 | 11.3 | 5.2 | 2.9 | 3.7 | 10.5 |
| Net margin | 27.6% | -5.6% | -33.5% | 35.3% | 20.5% | 11.2% | 14.6% | 35.3% |
| |
| Basic EPS | $0.68 | ($0.08) | ($0.32) | $0.78 | $0.36 | $0.20 | $0.27 | $0.74 |
| Diluted EPS | $0.67 | ($0.08) | ($0.31) | $0.76 | $0.35 | $0.20 | $0.26 | $0.71 |
| |
| Shares outstanding (basic) | 14.9 | 14.8 | 14.5 | 14.5 | 14.5 | 14.4 | 14.0 | 14.3 |
| Shares outstanding (diluted) | 15.3 | 14.8 | 15.0 | 15.0 | 14.9 | 14.8 | 14.6 | 14.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |